A Comprehensive Review of Advanced Biomarkers for Chronic Kidney Disease in Older Adults: Current Insights and Future Directions
Authors:
Open Access
- 28 September 2024
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 16 (9) , e70413
Abstract
Chronic kidney disease (CKD) is a growing health concern, particularly in older adults, due to its high prevalence and association with increased morbidity and mortality. Early detection and effective management are crucial to slowing disease progression and reducing complications such as cardiovascular events and end-stage renal disease (ESRD). Traditional biomarkers, including serum creatinine and estimated glomerular filtration rate (eGFR), often have limitations in older populations, where age-related physiological changes can obscure early signs of kidney dysfunction. Advanced biomarkers offer a more precise and comprehensive understanding of kidney health, providing insights into pathological processes such as inflammation, fibrosis, oxidative stress, and tubular injury. These biomarkers have the potential to enhance early diagnosis, predict disease progression, and inform personalized treatment approaches, particularly in the elderly. This review explores the current landscape of advanced biomarkers for CKD in older adults, highlighting their clinical utility and limitations. Key biomarkers, including those related to inflammation (C-reactive protein, interleukin-6), fibrosis (transforming growth factor-beta, collagen degradation products), oxidative stress (F2-isoprostanes, malondialdehyde), and tubular injury (kidney injury molecule-1, neutrophil gelatinase-associated lipocalin), are examined in the context of CKD. Emerging technologies, such as multi-omics and machine learning, are also discussed as they offer new opportunities for biomarker discovery and integration into clinical practice. While challenges remain, including the need for longitudinal studies and better standardization, advanced biomarkers hold promise for transforming CKD management in older adults, paving the way for earlier detection, better risk stratification, and more targeted therapeutic interventions.Keywords
This publication has 79 references indexed in Scilit:
- Chronic kidney disease and gut microbiotaHeliyon, 2023
- Application of explainable artificial intelligence in medical health: A systematic review of interpretability methodsInformatics in Medicine Unlocked, 2023
- Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic reviewImmunity, Inflammation and Disease, 2023
- Integration of artificial intelligence and multi-omics in kidney diseasesFundamental Research, 2023
- Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2022
- AI applications in functional genomicsComputational and Structural Biotechnology Journal, 2021
- Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational StudyDiabetes Therapy, 2021
- Chronic Kidney Disease Diagnosis and ManagementJAMA, 2019
- Beyond chronic kidney disease: the diagnosis of Renal Disease in the Elderly as an unmet need. A position paper endorsed by Italian Society of Nephrology (SIN) and Italian Society of Geriatrics and Gerontology (SIGG)Journal Of Nephrology, 2019
- Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross‐sectional study and review of literatureJournal of Cachexia, Sarcopenia and Muscle, 2012